source
- Flagship Pioneering invests £100 million to launch AI-focused biotech incubation lab in LondonFlagship Pioneering announced a £100 million investment to establish its first AI-focused biotech incubation unit outside Cambridge, locating it in London. The new Flagship Origination Lab, U.K.,…
- AstraZeneca and Alexion receive FDA nod for Klygefa, a weekly self-administered myasthenia gravis therapyAstraZeneca and Alexion announced that the U.S. Food and Drug Administration approved their joint drug Klygefa (gefurulimab) on Monday. Klygefa is a self-administered biologic designed for patient…